Skip to main content
MDT
NYSE Life Sciences

FDA 批准美敦力 Stealth Axis™ 外科手术系统用于颅部和耳鼻喉手术

feedReported by Reuters
Sentiment info
Positive
Importance info
7
Price
$87.19
Mkt Cap
$112.558B
52W Low
$79.55
52W High
$106.33
Market data snapshot near publication time

summarizeSummary

美敦力获得FDA批准其Stealth Axis™ Surgical System，用于颅部和耳鼻喉手术。该监管批准扩大了公司在神经外科和耳鼻喉市场的产品组合，提供了新的精确外科导航技术。该批准是美敦力的一项积极发展，继最近获得FDA批准其OmniaSecure除颤导线后，并对公司最近下调2026财年非GAAP EPS指导提供了抵消。这对于美敦力这样规模的公司来说，单一产品的批准是一个微小的积极信号，表明持续的创新和未来收入流的潜力。交易者将监测该新系统的商业推出和市场采用情况。

在该公告发布时，MDT的交易价格为$87.19，交易所为NYSE，所属行业为Life Sciences，市值约为$1125.6亿。 52周交易区间为$79.55至$106.33。 这则新闻被评估为积极市场情绪，重要性评分为7/10。 来源：Reuters。

show_chartPrice Chart

Share this article

Copied!

feed MDT - Latest Insights

MDT
Apr 25, 2026, 12:34 PM EDT
Source: Reuters
Importance Score:
8
Medtronic's Sphere-9 Catheter for VT Earns FDA Breakthrough Device Designation
Sentiment: Positive
View Wiseek Article
MDT
Apr 23, 2026, 8:14 AM EDT
Source: Reuters
Importance Score:
8
US to Speed Up Medicare Payments for New Medical Devices, Cutting Reimbursement Wait Times to Two Months
Sentiment: Positive
View Wiseek Article
MDT
Apr 20, 2026, 7:50 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Medtronic Finalizes CathWorks Acquisition, Bolstering Cardiovascular Leadership
Sentiment: Positive
View Wiseek Article
MDT
Mar 27, 2026, 9:01 AM EDT
Source: Reuters
Importance Score:
7
FDA Clears Medtronic's Stealth Axis™ Surgical System for Cranial, ENT Procedures
Sentiment: Positive
View Wiseek Article
MDT
Mar 24, 2026, 4:43 PM EDT
Source: Wiseek News
Importance Score:
8
Medtronic Cuts FY26 EPS Guidance by Over 2% on MiniMed Flex Charge, Dilution
Sentiment: Negative
View Wiseek Article
MDT
Mar 24, 2026, 4:42 PM EDT
Filing Type: 8-K
Importance Score:
7
Medtronic Lowers FY2026 EPS Guidance by $0.12/Share Due to MiniMed Flex Launch Costs and IPO Dilution
Sentiment: Negative
View Wiseek Article
MDT
Mar 24, 2026, 9:25 AM EDT
Source: dpa-AFX
Importance Score:
7
Medtronic Secures Exclusive Distribution for FDA-Approved ViaVerte System, Bolstering Pain Portfolio
Sentiment: Positive
View Wiseek Article
MDT
Mar 23, 2026, 9:38 AM EDT
Source: dpa-AFX
Importance Score:
7
Medtronic's OmniaSecure Lead First to Win FDA Approval for Advanced Cardiac Pacing
Sentiment: Positive
View Wiseek Article
MDT
Mar 10, 2026, 6:45 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Medtronic to Acquire Scientia Vascular, Expanding Medical Device Portfolio
Sentiment: Neutral
View Wiseek Article
MDT
Mar 06, 2026, 12:11 PM EST
Source: Reuters
Importance Score:
8
Medtronic's MiniMed Unit Shares Drop 4.8% in Nasdaq Debut, Valued at $5.3 Billion
Sentiment: Negative
View Wiseek Article